FENNEC PHARMACEUTICALS INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2003 | -2,549.4% | -2,549.4% | — |
| FY2004 | -41.3% | -41.3% | — |
| FY2005 | -125.2% | -125.2% | — |
| FY2006 | -1,296.5% | -1,296.5% | — |
| FY2007 | -94.4% | -94.4% | — |
| FY2008 | -445.5% | -445.5% | — |
| FY2009 | -741.9% | -741.9% | — |
| FY2010 | 158.8% | 158.8% | -130.5% |
| FY2011 | -3,937.0% | -3,937.0% | 87.6% |
| FY2012 | 104.2% | 104.2% | -218.3% |
| FY2013 | -126.8% | -126.8% | 105.3% |
| FY2014 | -355.0% | -355.0% | -91.7% |
| FY2015 | -120.3% | -120.3% | -64.7% |
| FY2016 | -78.1% | -78.1% | -70.2% |
| FY2017 | -26.3% | -26.3% | -24.8% |
| FY2018 | -46.4% | -46.4% | -43.1% |
| FY2019 | -107.6% | -107.6% | -90.3% |
| FY2020 | -62.3% | -62.3% | -57.6% |
| FY2021 | -110.0% | -110.0% | -77.4% |
| FY2022 | 923.1% | -106.2% | -88.0% |
| FY2023 | 138.1% | -83.1% | -59.7% |
| FY2024 | 7.4% | -3.2% | -1.0% |
| FY2025 | -27.5% | -27.5% | -13.8% |